Megan Wilcox v. HHS - HPV, systemic lupus erythematosus (2015)

Filed 2011-12-14Decided 2015-02-13Vaccine HPV
compensated$22,000

Case summary [AI summaries can sometimes make mistakes]

Megan Wilcox filed a petition on December 14, 2011, alleging that the human papillomavirus (HPV) vaccine she received on December 29, 2008, caused her to develop systemic lupus erythematosus (SLE) with residual effects lasting more than six months. Respondent denied that the HPV immunization caused petitioner's alleged SLE or any other injury.

The parties filed a joint stipulation on August 25, 2014, agreeing to resolve the case. Special Master Christian J.

Moran reviewed the stipulation, found it reasonable, and adopted it as the decision of the Court. Petitioner was awarded a lump sum of $22,000.00, representing compensation for all damages available under 42 U.S.C. § 300aa-15(a).

The public decision does not describe the onset of symptoms, specific medical tests, treatments, or expert witnesses. Petitioner was represented by Ronald C.

Homer of Conway, Homer & Chin-Caplan, P.C., and respondent was represented by Vincent Matanoski of the U.S. Department of Justice.

Theory of causation

Petitioner Megan Wilcox alleged that the HPV vaccine administered on December 29, 2008, caused her to develop systemic lupus erythematosus (SLE), with residual effects lasting more than six months. Respondent denied causation. The parties resolved the matter via joint stipulation filed on August 25, 2014. Special Master Christian J. Moran adopted the stipulation, awarding petitioner $22,000.00. The public decision does not detail the specific mechanism of causation, expert testimony, or clinical findings.

Source PDFs 2 total · 1 downloaded